BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.510
+0.095 (6.71%)
At close: Jun 21, 2024, 4:00 PM
1.560
+0.050 (3.31%)
After-hours: Jun 21, 2024, 7:18 PM EDT

BioAtla Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Revenue
000.250.435.2
Upgrade
Revenue Growth (YoY)
---41.72%-91.75%-51.07%
Upgrade
Gross Profit
000.250.435.2
Upgrade
Selling, General & Admin
25.9628.7938.4210.67.55
Upgrade
Research & Development
103.7379.3558.2719.9325.92
Upgrade
Operating Expenses
129.69108.1496.6930.5333.47
Upgrade
Operating Income
-129.69-108.14-96.44-30.1-28.27
Upgrade
Interest Expense / Income
0001.391.63
Upgrade
Other Expense / Income
-6.23-1.66-1.044.37-0.1
Upgrade
Pretax Income
-123.46-106.48-95.4-35.85-29.79
Upgrade
Net Income
-123.46-106.48-95.4-35.85-29.79
Upgrade
Shares Outstanding (Basic)
483935855
Upgrade
Shares Outstanding (Diluted)
483935855
Upgrade
Shares Change
22.74%12.63%310.07%-84.56%-
Upgrade
EPS (Basic)
-2.58-2.74-2.76-3.19-0.53
Upgrade
EPS (Diluted)
-2.58-2.74-2.76-3.19-0.53
Upgrade
Free Cash Flow
-104.11-90.69-63.14-36.92-11.15
Upgrade
Free Cash Flow Per Share
-2.18-2.33-1.83-4.38-0.20
Upgrade
Gross Margin
--100.00%100.00%100.00%
Upgrade
Operating Margin
---38576.00%-7016.08%-543.62%
Upgrade
Profit Margin
---38160.80%-8357.34%-572.96%
Upgrade
Free Cash Flow Margin
---25255.20%-8606.99%-214.50%
Upgrade
EBITDA
-122.24-105.28-94.07-33.46-27.3
Upgrade
EBITDA Margin
---37627.60%-7798.60%-525.08%
Upgrade
Depreciation & Amortization
1.221.21.331.010.86
Upgrade
EBIT
-123.46-106.48-95.4-34.46-28.16
Upgrade
EBIT Margin
---38159.60%-8033.57%-541.62%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).